| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alkermes Plc (ALKS) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. ALKS is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 231.6K | $9.01M | - | |
| Dir | 135.9K | $5.29M | - | |
| VP | 90.4K | $3.52M | -9,000 | |
| CFO | 36.7K | $1.43M | - | |
| Dir | 35.8K | $1.39M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 8, 2019 | Pops Richard F57 | Director And CEO, Alkermes Plc | Sale+OE | 100,000 | $19.78 | $1,978,444.86 | -6.5% | |
| Nov 6, 2019 | Landine Michael J | SVP, Corp Dev., Alkermes, Inc. | Sale+OE | 20,000 | $19.76 | $395,116.00 | -9.8% | |
| Sep 19, 2019 | Pops Richard F57 | Director And CEO, Alkermes Plc | Sale+OE | 100,000 | $21.54 | $2,153,550.00 | -12.2% | |
| Sep 12, 2019 | Pops Richard F57 | Director And CEO, Alkermes Plc | Sale+OE | 100,000 | $22.68 | $2,268,220.00 | -12.2% | |
| Sep 5, 2019 | Pops Richard F57 | Director And CEO, Alkermes Plc | Sale+OE | 100,000 | $20.18 | $2,017,830.00 | -12.2% | |
| May 23, 2019 | Pops Richard F57 | Director And CEO, Alkermes Plc | Sale+OE | 110,000 | $24.88 | $2,736,428.00 | -7.1% | |
| May 22, 2019 | Landine Michael J | SVP, Corp Dev., Alkermes, Inc. | Sale+OE | 20,000 | $24.93 | $498,532.00 | -9.8% | |
| May 9, 2019 | Gaffin David Joseph | SVP, CLO, Alkermes, Inc. | Sale+OE | 5,373 | $26.89 | $144,497.61 | -5.1% | |
| Apr 1, 2019 | Mitchell Paul J | Director | Sale+OE | 1,000 | $36.64 | $36,640.00 | -100% | |
| Mar 14, 2019 | Landine Michael J | SVP, Corp Dev., Alkermes, Inc. | Sale+OE | 25,000 | $33.05 | $826,372.50 | -11.9% |